StockData
CTT Pharmaceutical Holdings, Inc. logo

CTT Pharmaceutical Holdings, Inc. (CTTH) stock

CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 18, 2026
$0.06−0.00 (-0.17%)

Close on Oct 16, 2026Market cap $1.26MP/E –Yield –

CTT Pharmaceutical enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

CTT Pharmaceutical's enterprise value was $1.22M on Oct 16, 2026, against $1.32M a year earlier. Over the last 5 years it ranged from $153.36K to $2.50M, with a median of $1.01M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 16, 2026$1.22M-2.1%
2025Dec 31, 2025$1.25M+6.0%
2024Dec 31, 2024$1.18M+108.7%
2023Dec 29, 2023$564.82K+29.3%
2022Dec 30, 2022$436.90K-40.6%
2021Dec 31, 2021$735.37K-29.4%
2020Dec 31, 2020$1.04M-75.4%
2019Dec 31, 2019$4.23M-48.8%
2018Dec 31, 2018$8.27M+138.8%
2017Dec 29, 2017$3.46M+177.8%
2016Dec 30, 2016$1.25M+303.6%
2015Dec 31, 2015$308.99K-99.7%
2014Dec 31, 2014$91.14M+980.5%
2013Dec 31, 2013$8.43M-88.8%
2012Dec 31, 2012$75.10M-93.4%
2011Dec 30, 2011$1.15B–

More CTT Pharmaceutical figures

See a number that looks wrong?